Afuco™ Anti-Human CLEC2D ADCC Theraputic Antibody, ADCC Enhanced
Product sourcing details
- Place of Origin
- USA
Supplier: Creative Biolabs
Purchasing information
- Minimum order
- 1
- Lead time
- 15 Days
Please confirm with the supplier: Model / reference, Key specifications / compatibility, Samples, Export markets, Supply capacity.
Specifications
Anti-CLEC2D ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a monoclonal antibody that
is capable of specifically binding to lectin-like transcript 1 (LLT1), to polynucleotides encoding such antibodies and to cells that express such antibodies. Antibodies have utility in the treatment
of autoimmune diseases and cancer, in which LLT1- and CD161-expressing cells play a role in disease pathogenesis.
https://www.creativebiolabs.net/Anti-CLEC2D-ADCC-Enhanced-Antibody-20469.htm
- Company: Creative Biolabs
- Country: United States
- Founded Year: 2005
- Contact: Jerry Carter
